Axcella Health, Inc.

Axcella Health, Inc.

Axcella Health, Inc.

Overview
Date Founded

2008

Headquarters

840 Memorial Drive,Entrance on Blackstone Street,3rd floor,Cambridge, MA 02139

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Holding Companies
Medical Support Services
Biotechnology

Company Description

Axcella Health, Inc. provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology. It creates oral biologics to address health conditions caused or worsened by imbalances in amino acids that lead to harmful changes in cellular homeostasis. The firm's products enhance health by activating specific physiologic events that focus on amino acid imbalances and act to restore cellular homeostasis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn and David A. Berry in 2010 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Axcella Health, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

President & Chief Executive Officer

Senior Vice President of Finance & Chief Financial Officer

Executive Vice President, Chief Development Officer

Senior Vice President of Research & Development, Chief Scientific Officer

Director, Corporate Development

Senior Vice President of Clinical Development, Chief Medical Officer

Senior Vice President of Human Resources

Senior Vice President, Chief Intellectual Property Officer

Senior Vice President, Chief Regulatory Science, Patient Advocacy & Pharmacovigilance Officer

Board of Directors

Executive Partner at Flagship Pioneering

Co-Founder at Gurnet Point Capital LLC

Co-Founder at Axcella Health, Inc.

Founder at Fate Therapeutics, Inc.

Chief Financial Officer at bluebird bio, Inc.

President at Moderna, Inc.

President, Chief Executive Officer & Director at Nestlé Health Science SA

Vice President, R&D & Head of Cardiovascular, Renal & Metabolic Innovative Medicines at MedImmune LLC

President & Chief Executive Officer at Axcella Health, Inc.

Senior Associate Dean, Faculty Development at Harvard University - Harvard Business School

Paths to Axcella Health, Inc.
Potential Connections via
Relationship Science
You
Axcella Health, Inc.
Advisors & Consultants
Advisor

Director of the US Department of Energy Center on BioEnergy at Massachusetts Institute of Technology

Advisor

Co-Founder at Indigo Agriculture, Inc.

Legal Advisor

National Co-Chair, Life Sciences Practice at Goodwin Procter LLP

Investors
Details Hidden
Details Hidden

Flagship Pioneering focuses on investments in the following sectors: (1) therapeutics (2) life science tools and diagnostics and (3) bioenergy and clean technology. The firm looks for companies with exceptional management teams and significant commercial opportunities resulting from market discontinuities or technology breakthroughs. Flagship Ventures typically serves as lead investor. The majority of their investments are seed or first round investments. Initial investments range from $250,000 to $5 million, with typically initial investments ranging from $2.5 million to $4 million. Flagship Ventures may invest up to $15 million to $20 million over the life of a venture and typically forms syndicates that include other venture capital firms

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Axcella Health, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Axcella Health, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Axcella Health, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/axcella-health-inc-119666292
  • https://relationshipscience.com/organization/axcella-health-inc-119666292